Synapse Therapeutics Inc
NPI 1225026594 · Community/Retail Pharmacy · Glendale, CA
Enrolled with Medicare as Dme Supplier - Pharmacy · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Synapse Therapeutics Inc is a Community/Retail Pharmacy organization in Glendale, CA (NPI 1225026594).
Provider details
- NPI number
- 1225026594
- Entity type
- Organization
- Primary specialty
- Community/Retail PharmacySuppliers
- Organization subpart
- No
- Authorized official
- Arthur Avetisyan, Ceo/Sec/Cfo/Dir/President(818) 242-5887
Specialties & taxonomies
Suppliers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure38% of score
20 yrs in NPPES registry
- Profile completeness38% of score
100% of core fields populated
- Practice footprint23% of score
1 documented practice location
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
Practice location
Mailing address
Other names (DBA / former)
- Doing business as
- Western Ave Pharmacy
Registry dates
- Enumerated
- 2005-10-11
- Last updated
- 2023-10-10
- Certified
- 2023-10-10
Frequently asked questions
- What is Synapse Therapeutics Inc's NPI number?
- Synapse Therapeutics Inc's National Provider Identifier (NPI) is 1225026594, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What type of organization is Synapse Therapeutics Inc?
- Synapse Therapeutics Inc is classified in the NPPES registry as Community/Retail Pharmacy (Suppliers).
- Where is Synapse Therapeutics Inc located?
- Synapse Therapeutics Inc's practice location on file with NPPES is 501 Western Ave, Glendale, CA 91201-2870.
- What is Synapse Therapeutics Inc's phone number?
- The practice phone number listed in the NPPES registry for Synapse Therapeutics Inc is (818) 242-5887.
- Does Synapse Therapeutics Inc accept Medicare?
- Synapse Therapeutics Inc is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Who is the authorized official for Synapse Therapeutics Inc?
- The authorized official listed on Synapse Therapeutics Inc's NPPES record is Arthur Avetisyan, Ceo/Sec/Cfo/Dir/President. The authorized official registers and maintains the organization's NPI and is not necessarily its owner.
- Is Synapse Therapeutics Inc's NPI active?
- Yes — Synapse Therapeutics Inc's NPI (1225026594) is active in the NPPES registry as of the last update on 2023-10-10.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.